Entocort EC - Budesonide capsules - ASTRAZENECA - Oral form of corticosteroid for Tx of mild to moderate Crohn's disease

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2001年 / 36卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：774 / +
页数：2
相关论文
共 50 条
  • [41] Oral budesonide for maintenance of remission of Crohn's disease: a pooled safety analysis
    Lichtenstein, G. R.
    Bengtsson, B.
    Hapten-White, L.
    Rutgeerts, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (06) : 643 - 653
  • [42] The effect of acute treatment with budesonide on Body Mineral Density in Greek patients with newly diagnosed mild-to-moderate Crohn's disease
    Mantzaris, Gerassimos J.
    Kalantzis, Christoforos N.
    Kokkinakis, Evangelos
    Roussos, Anastassios
    Koilakou, Stavroula
    Grivas, Efstratios
    Tsounis, Demetrius
    Raptis, Nickolaos
    Kalantzis, Nikolaos
    Triantafyllou, George
    Kalafatas, John
    GASTROENTEROLOGY, 2006, 130 (04) : A655 - A655
  • [43] Beclomethasone dipropionate for the treatment of mild-to-moderate crohn's disease: An open-label, budesonide-controlled, randomized study
    Tursi, A
    Giorgetti, GM
    Brandimarte, G
    Elisei, W
    Aiello, F
    MEDICAL SCIENCE MONITOR, 2006, 12 (06): : PI29 - PI32
  • [44] Budesonide controlled ileal release (CIR) capsules in prednisolone-dependent patients with Crohn's disease
    Cortot, A
    Colombel, JF
    Rutgeerts, P
    Lauritsen, K
    Malchow, H
    Hamling, J
    Winter, T
    Pallant, D
    Pettersson, E
    GASTROENTEROLOGY, 1999, 116 (04) : A692 - A693
  • [45] Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn's disease
    Lundin, P
    Naber, T
    Nilsson, M
    Edsbäcker, S
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (01) : 45 - 51
  • [46] Budesonide capsules versus prednisolone in children with active Crohn's disease: Results of a European multicenter trial
    Escher, JC
    Lindquist, B
    Hildebrand, H
    Cezard, JP
    Derkx, B
    Ferry, G
    Grand, R
    Griffiths, A
    Goulet, O
    Keller, K
    Lentze, M
    Murch, S
    Murphy, S
    Miller, V
    Mougenot, JF
    Ribes-Koninck, C
    Sanderson, I
    Taminiau, J
    Taylor, C
    Thomas, A
    Turck, D
    Veereman-Wauters, G
    Walker-Smith, J
    Winter, H
    Lyckegaard, EMS
    Persson, T
    Buller, H
    GASTROENTEROLOGY, 2002, 122 (04) : A12 - A12
  • [47] The Comparative Efficacy of Induction of Remission for Mesalamine, Sulfasalazine, and Budesonide for the Treatment of Mild to Moderate Crohn's Disease: A Bayesian Network Meta-Analysis
    Coward, Stephanie
    Kuenzig, Ellen
    Hazlewood, Glen
    Holmes, Rebecca
    Panaccione, Remo
    Ghosh, Subrata
    Seow, Cynthia H.
    Rezaie, Ali
    Kaplan, Gilaad
    GASTROENTEROLOGY, 2015, 148 (04) : S271 - S271
  • [48] Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
    Bartolini, Claudia
    Ferraro, Sara
    Convertino, Irma
    Bertani, Lorenzo
    Giometto, Sabrina
    Costa, Francesco
    Lucenteforte, Ersilia
    Cappello, Emiliano
    Valdiserra, Giulia
    Blandizzi, Corrado
    Gini, Rosa
    Tuccori, Marco
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 369 - 370
  • [49] Pilot study of an elimination diet in adults with mild to moderate Crohn's disease
    Narula, Neeraj
    Wong, Emily C. L.
    Moayyedi, Paul
    Reinisch, Walter
    Marshall, John K.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (12) : 1210 - 1219
  • [50] Case presentation:: Mild to moderate Crohn's disease of the small and large bowel
    Peña, AS
    Manoliu, RA
    Bloemena, E
    Cohen, A
    Lobo, A
    Rutgeerts, P
    Sachar, D
    DRUGS OF TODAY, 2000, 36 : 103 - 107
12345